{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:15:37Z","timestamp":1761016537262},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,10,19]],"date-time":"2006-10-19T00:00:00Z","timestamp":1161216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1471-2458-6-256","type":"journal-article","created":{"date-parts":[[2006,10,19]],"date-time":"2006-10-19T18:14:40Z","timestamp":1161281680000},"source":"Crossref","is-referenced-by-count":12,"title":["Management of high-risk patients with hypertension and left ventricular hypertrophy in Germany: differences between cardiac specialists in the inpatient and outpatient setting"],"prefix":"10.1186","volume":"6","author":[{"given":"Heinz","family":"V\u00f6ller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J","family":"Sonntag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Thiery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Wegscheider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich C","family":"Luft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Bestehorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,10,19]]},"reference":[{"issue":"9063","key":"553_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997, 349 (9063): 1436-1442. 10.1016\/S0140-6736(96)07495-8.","journal-title":"Lancet"},{"issue":"9269","key":"553_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(00)04824-8","volume":"357","author":"CD Mathers","year":"2001","unstructured":"Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD: Healthy life expectancy in 191 countries, 1999. Lancet. 2001, 357 (9269): 1685-1691. 10.1016\/S0140-6736(00)04824-8.","journal-title":"Lancet"},{"issue":"1A","key":"553_CR3","doi-asserted-by":"publisher","first-page":"19i","DOI":"10.1016\/S0002-9149(03)00505-8","volume":"92","author":"MF Linton","year":"2003","unstructured":"Linton MF, Fazio S: A practical approach to risk assessment to prevent coronary artery disease and its complications. Am J Cardiol. 2003, 92 (1A): 19i-26i. 10.1016\/S0002-9149(03)00505-8.","journal-title":"Am J Cardiol"},{"issue":"8 Suppl","key":"553_CR4","first-page":"III8","volume":"24","author":"AMJ Gotto","year":"2001","unstructured":"Gotto AMJ: How do we achieve optimal cardiovascular risk reduction?. Clin Cardiol. 2001, 24 (8 Suppl): III8-12.","journal-title":"Clin Cardiol"},{"issue":"1","key":"553_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","volume":"115","author":"AU Klingbeil","year":"2003","unstructured":"Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE: A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003, 115 (1): 41-46. 10.1016\/S0002-9343(03)00158-X.","journal-title":"Am J Med"},{"issue":"9311","key":"553_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","volume":"359","author":"B Dahlof","year":"2002","unstructured":"Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002, 359 (9311): 995-1003. 10.1016\/S0140-6736(02)08089-3.","journal-title":"Lancet"},{"key":"553_CR7","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1055\/s-2003-36871","volume":"128","author":"W Zidek","year":"2003","unstructured":"Zidek W, Dusing R, Haller H, Middeke M, Paul M, Schmieder R, Schrader J: New recommendations of the German Hypertension League for the drug treatment of hypertension. Dtsch Med Wochenschr. 2003, 128: 2468-2469. 10.1097\/00004872-200306000-00001.","journal-title":"Dtsch Med Wochenschr"},{"key":"553_CR8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","volume":"21","author":"Guidelines committee","year":"2003","unstructured":"Guidelines committee: European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003, 21: 1011-1053.","journal-title":"J Hypertens"},{"issue":"19","key":"553_CR9","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJ, Jones DW, Materson BJ, Oparil S, Wright JTJ, Roccella EJ: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289 (19): 2560-2571. 10.1001\/jama.289.19.2560.","journal-title":"JAMA"},{"issue":"15","key":"553_CR10","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","volume":"282","author":"MD Cabana","year":"1999","unstructured":"Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PAC, Rubin HR: Why Don't Physicians Follow Clinical Practice Guidelines?: A Framework for Improvement. JAMA. 1999, 282 (15): 1458-1465. 10.1001\/jama.282.15.1458.","journal-title":"JAMA"},{"issue":"6 Pt 1","key":"553_CR11","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0895-7061(98)00068-5","volume":"11","author":"HD Faulhaber","year":"1998","unstructured":"Faulhaber HD, Luft FC: Treatment of high blood pressure in Germany. Am J Hypertens. 1998, 11 (6 Pt 1): 750-753. 10.1016\/S0895-7061(98)00068-5.","journal-title":"Am J Hypertens"},{"key":"553_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/00004872-200403000-00009","volume":"22","author":"AM Sharma","year":"2004","unstructured":"Sharma AM, Wittchen HU, Kirch W, Pittrow D, Ritz E, G\u00f6ke B, Lehnert H, Tsch\u00f6pe D, Krause P, H\u00f6fler M, Pfister H, Bramlage P, Unger T: High prevalence and poor control of hypertension in primary care: cross sectional study. J Hypertens. 2004, 22: 479-486. 10.1097\/00004872-200403000-00009.","journal-title":"J Hypertens"},{"issue":"18","key":"553_CR13","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","volume":"289","author":"K Wolf-Maier","year":"2003","unstructured":"Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. J Am Med Ass. 2003, 289 (18): 2363-2369. 10.1001\/jama.289.18.2363.","journal-title":"J Am Med Ass"},{"issue":"3","key":"553_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0735-1097(96)00528-1","volume":"29","author":"IS Nash","year":"1997","unstructured":"Nash IS, Nash DB, Fuster V: Do cardiologists do it better?. J Am Coll Cardiol. 1997, 29 (3): 475-478. 10.1016\/S0735-1097(96)00528-1.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"553_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s003920170112","volume":"90","author":"A Baessler","year":"2001","unstructured":"Baessler A, Fischer M, Hengstenberg C, Holmer S, Hubauer U, Huf V, Mell S, Klein G, Riegger G, Schunkert H: [Inpatient rehabilitation improves implementation of therapeutic guidelines for secondary prevention in patients with coronary heart disease]. Z Kardiol. 2001, 90 (9): 646-654. 10.1007\/s003920170112.","journal-title":"Z Kardiol"},{"key":"553_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/archinte.1943.00210080052005","volume":"72","author":"R Gubner","year":"1943","unstructured":"Gubner R, Ungerleider HE: Electrocardiographic criteria of left ventricular hypertrophy. Arch Intern Med. 1943, 72: 196-209.","journal-title":"Arch Intern Med"},{"key":"553_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","volume":"37","author":"M Sokolow","year":"1949","unstructured":"Sokolow M, Lyon TP: The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949, 37: 161-186. 10.1016\/0002-8703(49)90562-1.","journal-title":"Am Heart J"},{"issue":"4","key":"553_CR18","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/01.CIR.90.4.1786","volume":"90","author":"D Levy","year":"1994","unstructured":"Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB: Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994, 90 (4): 1786-1793.","journal-title":"Circulation"},{"issue":"4","key":"553_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","volume":"55","author":"RB Devereux","year":"1977","unstructured":"Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977, 55 (4): 613-618.","journal-title":"Circulation"},{"issue":"6","key":"553_CR20","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/S0735-1097(84)80141-2","volume":"4","author":"RB Devereux","year":"1984","unstructured":"Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, Miller DH, Reis G, Alderman MH, Laragh JH: Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984, 4 (6): 1222-1230.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"553_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/archfami.8.5.414","volume":"8","author":"PM Diller","year":"1999","unstructured":"Diller PM, Smucker DR, David B, Graham RJ: Congestive heart failure due to diastolic or systolic dysfunction. Frequency and patient characteristics in an ambulatory setting. Arch Fam Med. 1999, 8 (5): 414-420. 10.1001\/archfami.8.5.414.","journal-title":"Arch Fam Med"},{"key":"553_CR22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/01621459.1988.10478639","volume":"83","author":"WS Cleveland","year":"1988","unstructured":"Cleveland WS, Devlin SJ: Locally Weighted Regression. An Approach to Regression Analysis by Local Fitting. J Am Stat Assoc. 1988, 83: 596-610. 10.2307\/2289282.","journal-title":"J Am Stat Assoc"},{"key":"553_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika. 1983, 70: 41-55. 10.2307\/2335942.","journal-title":"Biometrika"},{"issue":"8 Pt 2","key":"553_CR24","doi-asserted-by":"publisher","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","volume":"127","author":"DB Rubin","year":"1997","unstructured":"Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997, 127 (8 Pt 2): 757-763.","journal-title":"Ann Intern Med"},{"issue":"14","key":"553_CR25","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1161\/hc3901.096700","volume":"104","author":"J Mathew","year":"2001","unstructured":"Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf S: Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation. 2001, 104 (14): 1615-1621.","journal-title":"Circulation"},{"issue":"9169","key":"553_CR26","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(98)07614-4","volume":"353","author":"JE Dickerson","year":"1999","unstructured":"Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ: Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet. 1999, 353 (9169): 2008-2013. 10.1016\/S0140-6736(98)07614-4.","journal-title":"Lancet"},{"issue":"8","key":"553_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/sj.jhh.1001451","volume":"16","author":"J Hasford","year":"2002","unstructured":"Hasford J, Mimran A, Simons WR: A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Hum Hypertens. 2002, 16 (8): 569-575. 10.1038\/sj.jhh.1001451.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"553_CR28","first-page":"31","volume":"160","author":"JJ Caro","year":"1999","unstructured":"Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD: Persistence with treatment for hypertension in actual practice. Can Med Assoc J. 1999, 160 (1): 31-37.","journal-title":"Can Med Assoc J"},{"issue":"7404","key":"553_CR29","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","volume":"326","author":"MR Law","year":"2003","unstructured":"Law MR, Wald NJ, Morris JK, Jordan RE: Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003, 326 (7404): 1427-1420. 10.1136\/bmj.326.7404.1427.","journal-title":"BMJ"},{"issue":"27","key":"553_CR30","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1056\/NEJM199812313392701","volume":"339","author":"DR Berlowitz","year":"1998","unstructured":"Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA: Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998, 339 (27): 1957-1963. 10.1056\/NEJM199812313392701.","journal-title":"N Engl J Med"},{"issue":"1","key":"553_CR31","first-page":"64","volume":"160","author":"MG Myers","year":"1999","unstructured":"Myers MG: Compliance in hypertension: Why don't patients take their pills?. Can Med Assoc J. 1999, 160 (1): 64-65.","journal-title":"Can Med Assoc J"},{"issue":"9","key":"553_CR32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","volume":"135","author":"LS Phillips","year":"2001","unstructured":"Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS: Clinical inertia. Ann Intern Med. 2001, 135 (9): 825-834.","journal-title":"Ann Intern Med"},{"issue":"2","key":"553_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00228-004-0731-6","volume":"60","author":"D Pittrow","year":"2004","unstructured":"Pittrow D, Kirch W, Bramlage P, Lehnert H, Hofler M, Unger T, Sharma AM, Wittchen HU: Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol. 2004, 60 (2): 135-142. 10.1007\/s00228-004-0731-6.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"553_CR34","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00392-005-0234-1","volume":"94","author":"T Furstenberg","year":"2005","unstructured":"Furstenberg T, Bunzemeier H, Roeder N, Reinecke H: [Cardiovascular medicine in the German diagnosis-related group--(G-DRG) system 2005]. Z Kardiol. 2005, 94 (5): 360-370. 10.1007\/s00392-005-0234-1.","journal-title":"Z Kardiol"},{"issue":"9118","key":"553_CR35","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998, 351 (9118): 1755-1762. 10.1016\/S0140-6736(98)04311-6.","journal-title":"Lancet"},{"issue":"12","key":"553_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, the RENAAL Study Investigators: Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. N Engl J Med. 2001, 345 (12): 861-869. 10.1056\/NEJMoa011161.","journal-title":"N Engl J Med"},{"issue":"12","key":"553_CR37","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001, 345 (12): 851-860. 10.1056\/NEJMoa011303.","journal-title":"N Engl J Med"},{"issue":"5","key":"553_CR38","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0002-9149(98)00961-8","volume":"83","author":"IS Nash","year":"1999","unstructured":"Nash IS, Corrato RR, Dlutowski MJ, O'Connor JP, Nash DB: Generalist versus specialist care for acute myocardial infarction. Am J Cardiol. 1999, 83 (5): 650-654. 10.1016\/S0002-9149(98)00961-8.","journal-title":"Am J Cardiol"},{"issue":"15","key":"553_CR39","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/archinte.158.15.1596","volume":"158","author":"MT Donohoe","year":"1998","unstructured":"Donohoe MT: Comparing generalist and specialty care: discrepancies, deficiencies, and excesses. Arch Intern Med. 1998, 158 (15): 1596-1608. 10.1001\/archinte.158.15.1596.","journal-title":"Arch Intern Med"},{"issue":"3","key":"553_CR40","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0735-1097(95)00214-O","volume":"26","author":"TL Schreiber","year":"1995","unstructured":"Schreiber TL, Elkhatib A, Grines CL, O'Neill WW: Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol. 1995, 26 (3): 577-582. 10.1016\/0735-1097(95)00214-O.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"553_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1046\/j.1525-1497.1997.07105.x","volume":"12","author":"MH Chin","year":"1997","unstructured":"Chin MH, Friedmann PD, Cassel CK, Lang RM: Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med. 1997, 12 (9): 523-530. 10.1046\/j.1525-1497.1997.07105.x.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"553_CR42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.amjmed.2004.04.013","volume":"117","author":"E Guadagnoli","year":"2004","unstructured":"Guadagnoli E, Normand SL, DiSalvo TG, Palmer RH, McNeil BJ: Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure. Am J Med. 2004, 117 (6): 371-379. 10.1016\/j.amjmed.2004.04.013.","journal-title":"Am J Med"},{"issue":"8B","key":"553_CR43","doi-asserted-by":"publisher","first-page":"45H","DOI":"10.1016\/S0002-9149(97)00820-5","volume":"80","author":"TA Pearson","year":"1997","unstructured":"Pearson TA, Peters TD: The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol. 1997, 80 (8B): 45H-52H.","journal-title":"Am J Cardiol"},{"key":"553_CR44","first-page":"S2","volume":"3 Suppl 3","author":"GC Fonarow","year":"2002","unstructured":"Fonarow GC: The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes. Rev Cardiovasc Med. 2002, 3 Suppl 3: S2-S10.","journal-title":"Rev Cardiovasc Med"},{"key":"553_CR45","unstructured":"Anonymous: ASH Specialists Program. Available at http:\/\/www.ash-us.org\/specialist_program\/index.htm. Last access on 20 September 2006."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-6-256\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-6-256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-6-256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-6-256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T22:49:07Z","timestamp":1548197347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-6-256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,19]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["553"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-6-256","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,19]]},"article-number":"256"}}